RxDoctor Payments DataLook up a doctor →

Vincent Bryan, DO

Internal Medicine · Tulsa, OKNPI 1134129356

Payments from drug & device makers

$14,305in general payments, 2019–2025

Across 827 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$1K
  • Pfizer$910
  • Novartis$546
  • Bayer$524
  • plus $7K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)148$2,295
Novo Nordisk108$1,803
AstraZeneca61$1,290
Pfizer60$910
Novartis31$546
Bayer25$524
Lilly USA, LLC32$522
GSK29$504
Johnson & Johnson(2 entities)26$494
Astellas Pharma US Inc19$409
Merck32$373
Amarin Pharma, Inc.14$360
Kowa Pharmaceuticals America, Inc.24$359
Boehringer Ingelheim19$333
Takeda Pharmaceuticals U.S.A., Inc.18$306
UCB, Inc.11$272
Eisai Inc.12$233
Abbott13$218
Amgen(2 entities)12$209
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$202
Otsuka America Pharmaceutical, Inc.8$183
Dexcom, Inc.9$179
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$170
E.r. Squibb & Sons, L.L.C.10$141
Antares Pharma, Inc.8$122
Sanofi-aventis U.S. LLC7$118
Biohaven Pharmaceutical Holding Company Ltd.5$92
Viiv Healthcare Company5$79
Esperion Therapeutics, Inc.4$77
Idorsia Pharmaceuticals US Inc4$74
Aytu Biopharma, Inc.5$67
Exact Sciences4$64
Lexicon Pharmaceuticals, Inc.3$62
Nestle Healthcare Nutrition Inc.3$59
Axsome Therapeutics, Inc.2$54
Sumitomo Pharma America, Inc.3$50
Inspire Medical Systems, Inc.2$50
Teva Pharmaceuticals USA, Inc.2$41
Sunovion Pharmaceuticals Inc.2$38
Ultragenyx Pharmaceutical Inc.2$37
Sanofi Pasteur Inc.2$35
Clarus Therapeutics Inc.2$31
Biohaven Pharmaceuticals, Inc.2$31
Boston Scientific2$29
Currax Pharmaceuticals LLC2$27
Corium, LLC1$22
Almatica Pharma LLC1$20
Acadia Pharmaceuticals Inc1$20
Aimmune Therapeutics, Inc.1$19
Genentech USA, Inc.1$17
Sun Pharmaceutical Industries Inc.1$17
Biogen1$15
Lundbeck LLC1$15
Therapeuticsmd, Inc.1$15
Alfasigma USA, Inc.1$15
Ironwood Pharmaceuticals, Inc1$15
Insulet Corporation1$14
Jazz Pharmaceuticals Inc.1$14
Shire North American Group Inc1$12

How this compares

$14,305 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$164,412
Medicare patients
309
Services billed
11,811

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Tulsa

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →